Researchers have developed a potential cancer treatment method that targets tumor-related blood vessels by targeting nanoparticle-based avenues to surrogates of angiogenesis, such as receptors for vascular endothelial growth factor (VEGF) or integrins (27, 28). The gene discussed is VEGFA; the disease is neoplasm.